Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

Marie Skłodowska-Curie Action · Ended early

EvoZyme Development of a synthetic diversification platform for targeted EVOLUTION of ENZYMES supporting a sustainable bioeconomy – EvoZyme

Coordinator
Agencia Estatal Consejo Superior De Investigaciones Cientificas, Spain
Runs
1 January 2024 to 31 December 2025
Status
Ended early
EU funding
€165k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101109287

What the project is doing

In the project's own words, from its summary on CORDIS.

The ongoing climate change requires immediate actions to reduce the CO2 concentration in the atmosphere. One such action is the transition from a fossil-based to a bio-based economy that builds on CO2-derived one-carbon (C1) feedstocks like formate. To this end, synthetic C1 assimilation routes are being engineered into biotechnological relevant microbes. Among them, the reductive glycine pathway (rGlyP) bears enormous potential for biotechnological applications as it is short, energy efficient, and easy to engineer.

So far, optimization of growth on formate via the rGlyP was achieved by adaptive laboratory evolution, a time-consuming process that leads to incorporation of undesired mutations and does not allow targeted pathway optimization (debottlenecking). In EvoZyme, I aim to develop a Synthetic Biology platform for targeted evolution of pathway enzymes. This platform consists of specialized Escherichia coli strains that are equipped with state-of-the-art diversification machineries allowing tunable hyperdiversification/evolution of target enzymes.

Furthermore, the platform is capable of transferring the diversified enzyme libraries to various bacterial hosts. To benchmark the platform, I aim to debottleneck the rGlyP by targeting its core enzyme, the glycine cleavage system (GCS) which catalyzes the rate-limiting step of glycine synthesis. Diversification and optimization of the GCS will be tested in dedicated selection strains from different bacterial hosts that can only grow if a functional GCS is expressed.

Ultimately, optimized GCS variants will be expressed in a formatotrophic E. coli strain lacking a GCS. Improved formatotrophic growth will be analyzed in lab-scale bioreactors to determine techno-economic parameters required for the establishment of a formate bioeconomy. The platform developed in this project will enable debottlenecking of rate-limiting enzymes in virtually any pathway and presents a valuable tool for Synthetic Biology.

Topics

Who is involved

OrganisationCityCountryRole
Agencia Estatal Consejo Superior De Investigaciones CientificasMadridSpainCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI